GNVR Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 17, 2026
Report Source: 2026 1st Quarter Report
G
Genvor Inc. Stock Analysis GNVR
Genvor, Inc. is a research and development company, which engages in the development of plant health solutions. The company is headquartered in Henderson, Nevada and currently employs 2 full-time employees. The company went IPO on 2023-09-01. The Company’s proprietary BioCypher Algorithm combines computational biology, machine learning, and regulatory benchmarks to create peptides that optimize agricultural outcomes with biological safety. With multiple patents and proprietary peptides in active development, it offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks. The Company’s platform centers on the development of anti-microbial peptides (AMPs), which are designed to combat a broad spectrum of debilitating and destructive plant diseases including bacterial, fungal, and viral pathogens that threaten crop productivity worldwide.
Read More Genvor Inc (GNVR) Chart
Key Statistics of Genvor Inc (GNVR)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.50Volume
9353.00P/E Ratio (TTM)
-52 Week Range
Market Cap
17.22MAvg. Volume
5320.18Dividend Yield
-Financial Metrics & Statements of Genvor Inc (GNVR)
FAQ's for Genvor Inc (GNVR)
- According to Musaffa’s Shariah screening methodology, Genvor Inc (GNVR) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.